Update on the sexual impact of treatment for benign prostatic hyperplasia.
There is an established link between lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) and erectile dysfunction (ED). The medical and surgical management of LUTS can affect erectile function (EF), cause ejaculatory dysfunction (EjD) or affect libido. This article will review the effects of these therapies on sexual function.
Department of Urology, Ochsner Clinic Foundation, New Orleans, LA 70121, USA. jbell@ochsner.org
John Roger
JR
Bell
Eric
E
Laborde
D058891:5-alpha Reductase Inhibitors / Q000009:adverse effects; D058668:Adrenergic alpha-1 Receptor Antagonists / Q000009:adverse effects; D007172:Erectile Dysfunction / Q000209:etiology*; D006801:Humans; D007989:Libido; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000009:adverse effects; D011468:Prostatectomy / Q000009:adverse effects / Q000379:methods; D011470:Prostatic Hyperplasia / Q000628:therapy*
D058891:5-alpha Reductase Inhibitors; D058668:Adrenergic alpha-1 Receptor Antagonists; D058986:Phosphodiesterase 5 Inhibitors